Company / Working Capital
Insulet Corporation Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.2B
FY2025
5-year range
$949.3M / $1.4B
FY2021-FY2025
Trend
-9.5%
vs FY2024
Sector context
#27 of 165
Health Care
What the data says
Insulet Corporation's working capital of $1.2B is higher than 84% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from $314M in FY2016 to $1.4B in FY2024.
Based on SEC 10-K filings.
$1.2B in FY2025 with a 5-year CAGR of +3.5%. Top quartile in the Health Care sector.
Improved from $1.1B to $1.2B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +9.1%
- 5-Year CAGR
- +3.5%
- 10-Year CAGR
- -
Sector benchmark
+51.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.5%, indicating consistent growth.
- In FY2025, working capital decreased 9.5% year-over-year.
- Ranks #27 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2B | -9.5% |
| FY2024 | $1.4B | +20.4% |
| FY2023 | $1.1B | +19.2% |
| FY2022 | $949.3M | -13.8% |
| FY2021 | $1.1B | +5.8% |
| FY2020 | $1.0B | +140.2% |
| FY2019 | $433.3M | +25.4% |
| FY2018 | $345.6M | -23.4% |
| FY2017 | $451.1M | +43.6% |
| FY2016 | $314.3M | +150.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026